Search for in this collection

Subscribe to this collection to receive daily e-mail notification of new additions

Preview	Issue Date	Title / Name	Author(s)
	Apr-2005	Clinical practice: review. Can we prevent prostate cancer?	Chong, P.; Rashid, P.; Rashid, Prem
	May-2020	Assessment of error in the MV radiation isocenter position calculated with the Elekta XVI software	Chojnowski, J. M.; Warr, G. B.; Sykes, J. R.; Thwaites, D. I.; Chojnowski, Jacek M.; Warr, George
	Dec-2019	Assessing the dependency of the uncertainties in the Elekta Agility MLC calibration procedure on the focal spot position	Chojnowski, J. M.; Taylor, L. M.; Sykes, J. R.; Thwaites, D. I.; Chojnowski, Jacek M.; Taylor, Lee M.
	Jul-2021	A novel method to determine linac mechanical isocenter position and size and examples of specific QA applications	Chojnowski, J. M.; Sykes, J. R.; Thwaites, D. I.; Chojnowski, Jacek M.
	Jun-2021	Towards zero radiation isocentre size: minimising radiation beam isocentricity on Elekta linear accelerators by means of optimising look-up tables	Chojnowski, J. M.; Sykes, J. R.; Thwaites, D. I.; Chojnowski, Jacek M.
	Dec-2020	Practical beam steering of X-ray beams on Elekta accelerators: The effect of focal spot alignment on beam (symmetry and position) and radiation isocentre (size and position)	Chojnowski, J. M.; Sykes, J. R.; Thwaites, D. I.; Chojnowski, Jacek M.
	Sep-2017	Beam focal spot position: The forgotten linac QA parameter. An EPID-based phantomless method for routine Stereotactic linac QA	Chojnowski, J. M.; Barnes, M. P.; Sykes, J. R.; Thwaites, D. I.; Chojnowski, Jacek M.
	Dec-2017	Toxicity after post-prostatectomy image-guided intensity-modulated radiotherapy using Australian guidelines	Chin, S.; Aherne, N. J.; Last, A.; Assareh, H.; Shakespeare, T. P.; Chin, Stephen; Aherne, Noel; Last, Andrew; Shakespeare, Thomas P.
	Aug-2021	MONARCC: a randomised phase II study of panitumumab monotherapy and panitumumab plus 5-fluorouracil as first-line therapy for RAS and BRAF wildtype metastatic colorectal cancer: a study by the Australasian Gastrointestinal Trials Group (AGITG)	Siu, H. W. D.; Tebbutt, N.; Chantrill, L.; Karapetis, C.; Steer, C.; Wilson, K.; Espinoza, D.; Bailey, L.; Yip, S.; Cuff, J.; Pavlakis, N.; Thavaneswaran, S.; Briscoe, K.; Srivastav, R.; Shannon, J.; Segelov, E.; Tie, J.; Caird, S.; Francesconi, A.; Price, T.; Wuttke, M.; Ladwa, R.; Sjoquist, K.; Burge, M.; Briscoe, Karen
	Sep-2023	Outcomes of extensive stage extrapulmonary small cell cancer	Gandy, G.; Yip, P.Y.; Tognela, A.; Hayat, Faisal; Fox, William; Kok, P.S.; Hayat, Faisal; Fox, William
	Sep-2023	NUTMEG: A randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed older patients with glioblastoma	Sim, H. W.; Wachsmuth, L.; Barnes, E. H.; Yip, S.; Koh, E. S.; Hall, M.; Jennens, R.; Ashley, D. M.; Verhaak, R. G.; Heimberger, A. B.; Rosenthal, M. A.; Hovey, E. J.; Ellingson, B. M.; Tognela, A.; Gan, H. K.; Wheeler, H.; Back, M.; McDonald, K. L.; Long, A.; Cuff, K.; Begbie, S.; Gedye, C.; Mislang, A.; Le, Hien; Johnson, M. O.; Kong, B. Y.; Simes, J. R.; Lwin, Z.; Khasraw, M.; Begbie, Stephen
	Jul-2008	Post-prostatectomy radiation therapy: consensus guidelines of the Australian and New Zealand Radiation Oncology Genito-Urinary Group	Sidhom, M. A.; Kneebone, A. B.; Lehman, M.; Wiltshire, K. L.; Millar, J. L.; Mukherjee, R. K.; Shakespeare, T. P.; Tai, K. H.; Shakespeare, Thomas P.
	Sep-2021	Survival outcomes for breast cancer patients who decline recommended treatment: a propensity score-matched analysis	Shingde, R.; Salindera, S.; Aherne, N. J.; Millard-Newton, L.; Houlton, A.; Sanderson, E.; Bowers, P.; Shakespeare, T. P.; Ross, W.; Salindera, Shehnarz; Aherne, Noel; Millard-Newton, Lee; Houlton, Adelene; Shakespeare, Thomas P.; Ross, William
	Jan-2022	Prognostic Value of the Neutrophil-Lymphocyte Ratio in Triple Negative Breast Cancer Patients	Shi, K.; Westhuyzen, J.; Gortman, A.; Shakespeare, T. P.; Aherne, N. J.; Shi, Kate; Westhuyzen, Justin; Shakespeare, Thomas P.; Aherne, Noel
	Feb-2024	Poor outcomes for trial-ineligible patients receiving polatuzumab for relapsed/refractory diffuse large B-cell lymphoma in routine care: An Australian Lymphoma and Related Diseases Registry project	Shaw, B.; Chung, E.; Wellard, C.; Yoo, E.; Bennett, R.; Birks, C.; Johnston, A.; Cheah, C. Y.; Hamad, N.; Simpson, J.; Barraclough, A.; Ku, M.; Viiala, N.; Ratnasingam, S.; Armytage, T.; Cochrane, T.; Chong, G.; Lee, D.; Manos, K.; Keane, C.; Wallwork, S.; Opat, S.; Hawkes, E. A.; Simpson, Jock
	Sep-2023	Prostate-specific membrane antigen positron emission tomography detected local failure after post-prostatectomy radiation therapy: Low rates of out-of-field recurrence validates current Australian prostate bed contouring guidelines	Shakespeare, T. P.; Yap, S. Z. L.; Hsieh, M.; Tahir, A. R. M.; Armstrong, S.; Shakespeare, Thomas P.; Yap, Shaun Z.; Hsieh, Michael; Tahir, Abdul R. M.
	Mar-2016	Can we avoid dose escalation for intermediate-risk prostate cancer in the setting of short-course neoadjuvant androgen deprivation?	Shakespeare, T. P.; Wilcox, S. W.; Aherne, N. J.; Shakespeare, Thomas P.; Wilcox, Shea; Aherne, Noel
	May-2016	Can we avoid high levels of dose escalation for high-risk prostate cancer in the setting of androgen deprivation?	Shakespeare, T. P.; Wilcox, S. W.; Aherne, N. J.; Shakespeare, Thomas P.; Wilcox, Shea; Aherne, Noel
	Mar-2020	Choosing between conventional and hypofractionated prostate cancer radiation therapy: Results from a study of shared decision-making	Shakespeare, T. P.; Westhuyzen, J.; Fai, T. L. Y.; Aherne, N. J.; Shakespeare, Thomas P.; Westhuyzen, Justin; Aherne, Noel
	Aug-2007	Is rural radiation oncology practice quality as good as the big smoke? Results of the Australian radiotherapy single machine unit trial	Shakespeare, T. P.; Turner, M.; Chapman, A.; Shakespeare, Thomas P.